Financials:
The company has posted income from operations, including increase in inventories, of Rs.1567.57 lakhs as compared to previous quarter (ending 30/09/2006) income of Rs.1545.67 lakhs. EBIDTA stood at Rs.669.23 lakhs and profit after tax of Rs.160.34 lakhs as compared to previous quarter of Rs.766.68 lakhs and Rs.344.73 lakhs respectively.
The company is in the process of achieving optimum capacity utilization of the Life Sciences facility which was commissioned in the previous quarter. Consequent to this gestation, there is a reduction in the EBIDTA and PAT.
Revised Annual Guidance for the year ending March 31, 2007:
In view of the delay in achieving optimum utilization of the capacity at Life Sciences facility, the estimated revenues and profitability given as preliminary guidance is revised to a gross revenue of about Rs.63 to Rs.65 Crores with EBIDTA at 42 + (or) - 2% and PAT at 15 + (or) - 2% of gross revenue.